{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:52:51Z","timestamp":1792601571522,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Jornal de Pediatria"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jped.2024.08.005","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T03:42:31Z","timestamp":1725939751000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosis"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6798-0379","authenticated-orcid":false,"given":"Zi-Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2413-8084","authenticated-orcid":false,"given":"Hong-Yun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5860-0696","authenticated-orcid":false,"given":"Wei-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-5743","authenticated-orcid":false,"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0114-9008","authenticated-orcid":false,"given":"Hong-Hao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5520-8867","authenticated-orcid":false,"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-4677","authenticated-orcid":false,"given":"Yun-Ze","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6505-8630","authenticated-orcid":false,"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5757-9252","authenticated-orcid":false,"given":"Hua-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0379-4369","authenticated-orcid":false,"given":"Xiao-Tong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4488-7040","authenticated-orcid":false,"given":"Tian-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3727-1192","authenticated-orcid":false,"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-1431","authenticated-orcid":false,"given":"Lei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5334-9706","authenticated-orcid":false,"given":"Zhi-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jped.2024.08.005_bib0001","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.2019000934","article-title":"Langerhans cell histiocytosis","volume":"135","author":"Rodriguez-Galindo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jped.2024.08.005_bib0002","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/hon.2857","article-title":"Langerhans cell histiocytosis: version 2021","volume":"39","author":"Gulati","year":"2021","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jped.2024.08.005_bib0003","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","article-title":"Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms","volume":"25","author":"Durham","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jped.2024.08.005_bib0004","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jped.2024.08.005_bib0005","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-cell histiocytosis","volume":"379","author":"Allen","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jped.2024.08.005_bib0006","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S1470-2045(17)30031-1","article-title":"Histiocytoses: emerging neoplasia behind inflammation","volume":"18","author":"Haroche","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jped.2024.08.005_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2014-12-569301","article-title":"How I treat Langerhans cell histiocytosis","volume":"126","author":"Allen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jped.2024.08.005_bib0008","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.4049\/jimmunol.163.6.3511","article-title":"Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment","volume":"163","author":"Tazi","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jped.2024.08.005_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156378","article-title":"Immune microenvironment associated with the severity of Langerhans cell histiocytosis in children","volume":"171","author":"Cai","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.jped.2024.08.005_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cyto.2017.05.026","article-title":"Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis","volume":"97","author":"Morimoto","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jped.2024.08.005_bib0011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clim.2018.06.004","article-title":"A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis","volume":"194","author":"Mitchell","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jped.2024.08.005_bib0012","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jped.2024.08.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108515","article-title":"The IL-2 - IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor","volume":"218","author":"Damoiseaux","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jped.2024.08.005_bib0014","first-page":"633","article-title":"Serum sCD25 is an indicator for rheumatoid arthritis-associated interstitial lung disease","volume":"42","author":"Cao","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jped.2024.08.005_bib0015","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.3390\/cancers13153702","article-title":"Serum sCD25 protein as a predictor of lack of long-term benefits from immunotherapy in non-small cell lung cancer: a pilot study","volume":"13","author":"Siemiatkowska","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jped.2024.08.005_bib0016","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00431-022-04398-8","article-title":"Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2","volume":"181","author":"Mostafa","year":"2022","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jped.2024.08.005_bib0017","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1365-2141.2002.03400.x","article-title":"Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis","volume":"117","author":"Rosso","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jped.2024.08.005_bib0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.24367","article-title":"Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years","volume":"60","author":"Haupt","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jped.2024.08.005_bib0019","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ajh.26829","article-title":"Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: results from the BCH-LCH 2014 protocol study","volume":"98","author":"Cui","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jped.2024.08.005_bib0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4143\/crt.2020.769","article-title":"Effectiveness and safety of Dabrafenib in the treatment of 20 Chinese children with BRAFV600E-Mutated Langerhans cell histiocytosis","volume":"53","author":"Yang","year":"2021","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.jped.2024.08.005_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155729","article-title":"Significance of serum Th1\/Th2 cytokine levels in underlying disease classification of childhood HLH","volume":"149","author":"Zhao","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.jped.2024.08.005_bib0022","article-title":"Genetic landscape and its prognostic impact in children with Langerhans cell histiocytosis","author":"Wang","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jped.2024.08.005_bib0023","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.3324\/haematol.2019.229187","article-title":"Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis","volume":"105","author":"Cui","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jped.2024.08.005_bib0024","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/08880018.2013.865095","article-title":"Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years\u2019 experience of 154 patients at a single center","volume":"31","author":"Lee","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jped.2024.08.005_bib0025","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood.2020005867","article-title":"Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH","volume":"137","author":"Sengal","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jped.2024.08.005_bib0026","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jped.2024.08.005_bib0027","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cytogfr.2022.06.003","article-title":"Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity","volume":"67","author":"Zhou","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jped.2024.08.005_bib0028","doi-asserted-by":"crossref","first-page":"11431","DOI":"10.1007\/s00432-023-04991-w","article-title":"Serum levels of soluble interleukin 2 receptor (sIL-2R), tumor necrosis factor-alpha (TNF-alpha), and immunoglobulin M are correlated with the disease extent in childhood Langerhans cell histiocytosis","volume":"149","author":"Wang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jped.2024.08.005_bib0029","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13023-022-02276-y","article-title":"Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis","volume":"17","author":"Wang","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jped.2024.08.005_bib0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjh.14140","article-title":"Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age","volume":"174","author":"Rigaud","year":"2016","journal-title":"Br J Haematol"}],"container-title":["Jornal de Pediatria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755724001116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021755724001116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:05:15Z","timestamp":1739955915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021755724001116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0021755724001116"],"URL":"https:\/\/doi.org\/10.1016\/j.jped.2024.08.005","relation":{},"ISSN":["0021-7557"],"issn-type":[{"value":"0021-7557","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosis","name":"articletitle","label":"Article Title"},{"value":"Jornal de Pediatria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jped.2024.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.","name":"copyright","label":"Copyright"}]}}